NCT01261741 - Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems | Biotech Hunter

Enrollment

299

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

September 30, 2011

Conditions

Memory DisorderRetention Disorder, CognitiveSubjective Cognitive ImpairmentMemory, Concentration or Attention Problems

Interventions

DRUG

Memantine

Each subject will receive memantine 10mg tablets once daily

DRUG

Placebo

Each subject will receive matching placebo tablets once daily

Trial Locations (14)

Klinische Forschung Berlin-Mitte, Mitte

Praxis Dr. Kühn, Oranienburg

Klinische Forschung Hannover-Mitte, Hanover

Universitätsklinikum der RWTH Aachen, Aachen

Praxis Dr. Reifschneider, Erbach im Odenwald

Praxis Dr. Heidenreich, Böblingen

Praxis Dr. Albrecht, Ellwangen

Praxis Dr. Pauls, München

Praxis Dr. Krause, Wolfratshausen

Universitätsklinikum Carl Gustav Carus, Dresden

ZSL Zentrum für medizinische Studien in Leipzig, Leipzig

Royal United Hospital, Bath

Community Pharmacology Services (CPS), Glasgow

Moorgreen Hospital, West End, Southampton